Significance Although the overwhelming majority of COVID-19-related deaths are due to respiratory failure, little is known about the host response to SARS-CoV-2 in lung parenchyma. By profiling the lung and colon transcriptome and lung proteome of nine patients who died of COVID-19 during the first wave of the pandemic in Wuhan, China, we obtained molecular insights into the host response to severe SARS-CoV-2 infection. Interestingly, all samples had a low viral burden, a finding that suggests the patients’ deaths may be due to uncontrolled host inflammatory processes rather than an active viral infection. Taken together, our findings shed light on COVID-19 pathophysiology and offer potential therapeutic targets for severe COVID-19 disease. Coronavirus disease 2019 (COVID-19), the global pandemic caused by SARS-CoV-2, has resulted thus far in greater than 933,000 deaths worldwide; yet disease pathogenesis remains unclear. Clinical and immunological features of patients with COVID-19 have highlighted a potential role for changes in immune activity in regulating disease severity. However, little is known about the responses in human lung tissue, the primary site of infection. Here we show that pathways related to neutrophil activation and pulmonary fibrosis are among the major up-regulated transcriptional signatures in lung tissue obtained from patients who died of COVID-19 in Wuhan, China. Strikingly, the viral burden was low in all samples, which suggests that the patient deaths may be related to the host response rather than an active fulminant infection. Examination of the colonic transcriptome of these patients suggested that SARS-CoV-2 impacted host responses even at a site with no obvious pathogenesis. Further proteomics analysis validated our transcriptome findings and identified several key proteins, such as the SARS-CoV-2 entry-associated protease cathepsins B and L and the inflammatory response modulator S100A8/A9, that are highly expressed in fatal cases, revealing potential drug targets for COVID-19.
【저자키워드】 COVID-19, SARS-CoV-2, neutrophil, fibrosis, NETosis, 【초록키워드】 coronavirus disease, Transcriptome, viral infection, proteomics, Coronavirus disease 2019, pandemic, Pathogenesis, Respiratory failure, SARS-COV-2 infection, disease severity, pulmonary fibrosis, neutrophil, Infection, lung, fibrosis, Proteins, host response, protease, immune, COVID-19 disease, global pandemic, Viral, pathophysiology, clinical, response, Wuhan, Patient, death, pathway, drug target, proteome, molecular, First wave, severe COVID-19 disease, cathepsin, S100A8, Inflammatory response, Analysis, Inflammatory, Pathways, lung parenchyma, host responses, neutrophil activation, fulminant infection, disease pathogenesis, Colon, examination, primary site, active viral infection, severe SARS, lung tissue, COVID-19-related death, potential therapeutic targets, viral burden, finding, potential therapeutic target, human lung tissue, offer, Host, immunological, feature, severe SARS-CoV-2, transcriptional, Wuhan, China, greater, caused, died, the patient, nine, majority, changes in, expressed, suggested, up-regulated, impacted, colonic, patients with COVID-19, Significance, the SARS-CoV-2, 【제목키워드】 proteomic, fatal COVID-19,